ArticleEuropean journal of haematology2026

Junctional Adhesion Molecule-A (JAM-A) Associates With High-Risk Disease in Multiple Myeloma Patients and a Structure-Based Rationally-Designed Peptide Inhibitor Attenuates Tumorigenic Features In Vitro and In Vivo.

Niamh McAuley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.